Copyright Reports & Markets. All rights reserved.

Global Dystrophin Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Dystrophin Market Overview

      • 1.1 Product Overview and Scope of Dystrophin
      • 1.2 Dystrophin Segment by Type
        • 1.2.1 Global Dystrophin Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 DS-5141
        • 1.2.3 Biostrophin
        • 1.2.4 BMBD-001
        • 1.2.5 NS-065
        • 1.2.6 Others
      • 1.3 Dystrophin Segment by Application
        • 1.3.1 Dystrophin Consumption Comparison by Application (2014-2025)
        • 1.3.2 Genetic Disorders
        • 1.3.3 Musculoskeletal Disorders
        • 1.3.4 Others
      • 1.3 Global Dystrophin Market by Region
        • 1.3.1 Global Dystrophin Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Dystrophin Market Size
        • 1.4.1 Global Dystrophin Revenue (2014-2025)
        • 1.4.2 Global Dystrophin Production (2014-2025)

      2 Global Dystrophin Market Competition by Manufacturers

      • 2.1 Global Dystrophin Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Dystrophin Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Dystrophin Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Dystrophin Production Sites, Area Served, Product Types
      • 2.5 Dystrophin Market Competitive Situation and Trends
        • 2.5.1 Dystrophin Market Concentration Rate
        • 2.5.2 Dystrophin Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Dystrophin Production Market Share by Regions

      • 3.1 Global Dystrophin Production Market Share by Regions
      • 3.2 Global Dystrophin Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Dystrophin Production
        • 3.4.1 North America Dystrophin Production Growth Rate (2014-2019)
        • 3.4.2 North America Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Dystrophin Production
        • 3.5.1 Europe Dystrophin Production Growth Rate (2014-2019)
        • 3.5.2 Europe Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Dystrophin Production (2014-2019)
        • 3.6.1 China Dystrophin Production Growth Rate (2014-2019)
        • 3.6.2 China Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Dystrophin Production (2014-2019)
        • 3.7.1 Japan Dystrophin Production Growth Rate (2014-2019)
        • 3.7.2 Japan Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Dystrophin Consumption by Regions

      • 4.1 Global Dystrophin Consumption by Regions
      • 4.2 North America Dystrophin Consumption (2014-2019)
      • 4.3 Europe Dystrophin Consumption (2014-2019)
      • 4.4 China Dystrophin Consumption (2014-2019)
      • 4.5 Japan Dystrophin Consumption (2014-2019)

      5 Global Dystrophin Production, Revenue, Price Trend by Type

      • 5.1 Global Dystrophin Production Market Share by Type (2014-2019)
      • 5.2 Global Dystrophin Revenue Market Share by Type (2014-2019)
      • 5.3 Global Dystrophin Price by Type (2014-2019)
      • 5.4 Global Dystrophin Production Growth by Type (2014-2019)

      6 Global Dystrophin Market Analysis by Applications

      • 6.1 Global Dystrophin Consumption Market Share by Application (2014-2019)
      • 6.2 Global Dystrophin Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Dystrophin Business

      • 7.1 Asklepios BioPharmaceutical Inc
        • 7.1.1 Asklepios BioPharmaceutical Inc Dystrophin Production Sites and Area Served
        • 7.1.2 Dystrophin Product Introduction, Application and Specification
        • 7.1.3 Asklepios BioPharmaceutical Inc Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 BioMarin Pharmaceutical Inc
        • 7.2.1 BioMarin Pharmaceutical Inc Dystrophin Production Sites and Area Served
        • 7.2.2 Dystrophin Product Introduction, Application and Specification
        • 7.2.3 BioMarin Pharmaceutical Inc Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Daiichi Sankyo Company Ltd
        • 7.3.1 Daiichi Sankyo Company Ltd Dystrophin Production Sites and Area Served
        • 7.3.2 Dystrophin Product Introduction, Application and Specification
        • 7.3.3 Daiichi Sankyo Company Ltd Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Editas Medicine Inc
        • 7.4.1 Editas Medicine Inc Dystrophin Production Sites and Area Served
        • 7.4.2 Dystrophin Product Introduction, Application and Specification
        • 7.4.3 Editas Medicine Inc Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Genethon SA
        • 7.5.1 Genethon SA Dystrophin Production Sites and Area Served
        • 7.5.2 Dystrophin Product Introduction, Application and Specification
        • 7.5.3 Genethon SA Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Nippon Shinyaku Co Ltd
        • 7.6.1 Nippon Shinyaku Co Ltd Dystrophin Production Sites and Area Served
        • 7.6.2 Dystrophin Product Introduction, Application and Specification
        • 7.6.3 Nippon Shinyaku Co Ltd Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Pfizer Inc
        • 7.7.1 Pfizer Inc Dystrophin Production Sites and Area Served
        • 7.7.2 Dystrophin Product Introduction, Application and Specification
        • 7.7.3 Pfizer Inc Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Sarepta Therapeutics Inc
        • 7.8.1 Sarepta Therapeutics Inc Dystrophin Production Sites and Area Served
        • 7.8.2 Dystrophin Product Introduction, Application and Specification
        • 7.8.3 Sarepta Therapeutics Inc Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 WAVE Life Sciences Ltd
        • 7.9.1 WAVE Life Sciences Ltd Dystrophin Production Sites and Area Served
        • 7.9.2 Dystrophin Product Introduction, Application and Specification
        • 7.9.3 WAVE Life Sciences Ltd Dystrophin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Dystrophin Manufacturing Cost Analysis

      • 8.1 Dystrophin Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Dystrophin
      • 8.4 Dystrophin Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Dystrophin Distributors List
      • 9.3 Dystrophin Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Dystrophin Market Forecast

      • 11.1 Global Dystrophin Production, Revenue Forecast
        • 11.1.1 Global Dystrophin Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Dystrophin Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Dystrophin Price and Trend Forecast (2019-2025)
      • 11.2 Global Dystrophin Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Dystrophin Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Dystrophin Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Dystrophin Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Dystrophin Production, Revenue Forecast (2019-2025)
      • 11.3 Global Dystrophin Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Dystrophin Consumption Forecast (2019-2025)
        • 11.3.2 Europe Dystrophin Consumption Forecast (2019-2025)
        • 11.3.3 China Dystrophin Consumption Forecast (2019-2025)
        • 11.3.4 Japan Dystrophin Consumption Forecast (2019-2025)
      • 11.4 Global Dystrophin Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Dystrophin Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Dystrophin market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Dystrophin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dystrophin market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Asklepios BioPharmaceutical Inc
        BioMarin Pharmaceutical Inc
        Daiichi Sankyo Company Ltd
        Editas Medicine Inc
        Genethon SA
        Nippon Shinyaku Co Ltd
        Pfizer Inc
        Sarepta Therapeutics Inc
        WAVE Life Sciences Ltd

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        DS-5141
        Biostrophin
        BMBD-001
        NS-065
        Others

        Segment by Application
        Genetic Disorders
        Musculoskeletal Disorders
        Others

        Buy now